APA (7th ed.) Citation

JK, D., M, L., P, S., S, D., DM, C., L, B., . . . X, G. (2026). Population Pharmacokinetic/Pharmacodynamic Modeling of Donidalorsen, an Antisense Oligonucleotide in Development for Prophylaxis of Hereditary Angioedema. CPT: pharmacometrics & systems pharmacology, 15(2), e70206. https://doi.org/10.1002/psp4.70206

Chicago Style (17th ed.) Citation

JK, Diep, Liu M, Singh P, Dorow S, Cohn DM, Bordone L, Newman KB, and Gao X. "Population Pharmacokinetic/Pharmacodynamic Modeling of Donidalorsen, an Antisense Oligonucleotide in Development for Prophylaxis of Hereditary Angioedema." CPT: Pharmacometrics & Systems Pharmacology 15, no. 2 (2026): e70206. https://doi.org/10.1002/psp4.70206.

MLA (9th ed.) Citation

JK, Diep, et al. "Population Pharmacokinetic/Pharmacodynamic Modeling of Donidalorsen, an Antisense Oligonucleotide in Development for Prophylaxis of Hereditary Angioedema." CPT: Pharmacometrics & Systems Pharmacology, vol. 15, no. 2, 2026, p. e70206, https://doi.org/10.1002/psp4.70206.